Cargando…
Engineering the gut for insulin replacement to treat diabetes
The gut epithelium's large surface area, its direct exposure to ingested nutrients, its vast stem cell population and its immunotolerogenic environment make it an excellent candidate for therapeutic cells to treat diabetes. Thus, several attempts have been made to coax immature gut cells to dif...
Autores principales: | Mojibian, Majid, Glavas, Maria M, Kieffer, Timothy J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854511/ https://www.ncbi.nlm.nih.gov/pubmed/27186362 http://dx.doi.org/10.1111/jdi.12479 |
Ejemplares similares
-
Preface
por: Kieffer, Timothy J.
Publicado: (2016) -
Discovery of gastric inhibitory polypeptide and its subsequent fate: Personal reflections
por: Pederson, Raymond A, et al.
Publicado: (2016) -
Searching for the physiological role of glucose‐dependent insulinotropic polypeptide
por: Holst, Jens Juul, et al.
Publicado: (2016) -
Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion
por: Reimann, Frank, et al.
Publicado: (2016) -
Mechanisms of fat‐induced gastric inhibitory polypeptide/glucose‐dependent insulinotropic polypeptide secretion from K cells
por: Yamane, Shunsuke, et al.
Publicado: (2016)